Actuate Therapeutics

1. Elraglusib IIT readoutmid-2026Elraglusib IIT readout, mid-2026, notable
2. Elraglusib Ph3 start2H 2026Elraglusib Ph3 start, 2H 2026, routine
3. Elraglusib Oral Tablet Ph1 start2H 2026Elraglusib Oral Tablet Ph1 start, 2H 2026, routine
4. corporate listing updateJan 11, 2027corporate listing update, Jan 11, 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.